论文标题
调查蛋白质结构和动力学的侧链网络方法:SARS-COV-2尖峰蛋白作为说明性情况
Surveying the side-chain network approach to protein structure and dynamics: The SARS-CoV-2 spike protein as an illustrative case
论文作者
论文摘要
基于网络理论的方法为蛋白质不同动力学状态之间的全球结构连通性的变化提供了宝贵的见解。我们的目标是审查基于网络的分析以阐明这种变化,尤其是在微妙的构象变化的背景下。我们介绍了蛋白质结构网络的构建和分析的技术细节,包括非共价连通性和动态。我们根据渗透的物理概念研究了连通性的最佳标准的选择。我们强调了使用基于侧链网络指标的优势与主链测量相比。作为一个说明性的例子,我们应用了所描述的网络方法来研究SARS-COV-2峰值蛋白的闭合和部分开放状态之间的全局构象变化。峰值蛋白的这种构象变化对于冠状病毒的进入和融合到人类细胞至关重要。我们的分析揭示了尖峰蛋白的两个状态之间的全球结构重新定位,尽管两种状态在主链水平上的变化很小。我们还观察到结构中战略位置的一些差异,与它们的功能相关,并主张侧链网络分析的优势。最后,我们将变构视为配体和受体之间的微妙协同全球变化的观点,其结合将增强药物设计策略。
Network theory-based approaches provide valuable insights into the variations in global structural connectivity between differing dynamical states of proteins. Our objective is to review network-based analyses to elucidate such variations, especially in the context of subtle conformational changes. We present technical details of the construction and analyses of protein structure networks, encompassing both the non-covalent connectivity and dynamics. We examine the selection of optimal criteria for connectivity based on the physical concept of percolation. We highlight the advantages of using side-chain based network metrics in contrast to backbone measurements. As an illustrative example, we apply the described network approach to investigate the global conformational change between the closed and partially open states of the SARS-CoV-2 spike protein. This conformational change in the spike protein is crucial for coronavirus entry and fusion into human cells. Our analysis reveals global structural reorientations between the two states of the spike protein despite small changes between the two states at the backbone level. We also observe some differences at strategic locations in the structures, correlating with their functions, asserting the advantages of the side-chain network analysis. Finally we present a view of allostery as a subtle synergistic-global change between the ligand and the receptor, the incorporation of which would enhance the drug design strategies.